News
-
-
-
-
PRESS RELEASE
Vaderis Therapeutics Announces The New England Journal of Medicine Publishes Engasertib Proof-of-Concept and Long-Term Extension Results, Highlighting the Therapy's Potential for Patients with Hereditary Hemorrhagic Telangiectasia
Vaderis Therapeutics announces publication of engasertib proof-of-concept study results in The New England Journal of Medicine, showing potential for Hereditary Hemorrhagic Telangiectasia patients -
-
PRESS RELEASE
Aspire Biopharma Submits Pre-IND Meeting Request and Briefing Package to U.S. FDA for Sublingual Aspirin Product for Treatment of Suspected Acute Myocardial Infarction (Heart Attack)
Aspire Biopharma Holdings, Inc. submits Pre-IND meeting request to FDA for fast-acting sublingual aspirin formulation to treat acute myocardial infarction, demonstrating rapid action and potential for FDA approval -
PRESS RELEASE
Jaguar Health Makes Submission to EMA Regarding EU Approval Pathway for Canalevia for General Diarrhea in Dogs Based on Data from Completed Study
Jaguar Health, Inc. requests advice from EMA on EU approval pathway for Canalevia® in treating general diarrhea in dogs. Novel non-antibiotic approach targets a significant market gap -
-
-
PRESS RELEASE
Sarama Partners With InvestorHub to Strengthen Investor Engagement
Sarama Resources Ltd. partners with InvestorHub to launch an interactive website, Investor Hub, enhancing transparency with shareholders and investors. The Company aims to provide insights on growth strategy and value creation initiatives
